Yale’s Sabrina Diano is first woman to receive the Helmholtz Diabetes Award
Yale School of Medicine metabolism researcher Sabrina Diano has been selected to receive the Helmholtz Diabetes Award during the 6th annual Helmholtz Conference Sept. 26-28, 2018 in Munich, Germany. Diano is the first woman to receive the award, which recognizes outstanding contributions by a leading scientist in the field of diabetes research. She will deliver the Heimholtz Diabetes Lecture during the conference.
Diano is a professor in the Departments of Obstetrics, Gynecology & Reproductive Sciences, Neuroscience, and Comparative Medicine at Yale School of Medicine. She is also a member of the Program in Integrative Cell Signaling and Neurobiology of Metabolism, and director of the Reproductive Neuroscience Group at Yale School of Medicine.
Diano has published many studies in top research journals such as Cell, Nature, Cell Metabolism, Nature Medicine, and Proceedings of the National Academy of Sciences.
These studies have broadened understanding of how neurons in the brain that regulate appetite also affect systemic glucose levels. She has also helped to pinpoint a mechanism in part of the brain that is key to sensing glucose levels in the blood, linking it to both type 1 and type 2 diabetes.
Diano’s research has important implications for understanding the pathogenesis of metabolic syndrome, obesity, and type 2 diabetes, disorders that are the leading cause of morbidity and mortality in the U.S., and the developed world in general, with the highest financial burden on the national economy.